Allergic reaction are immune responses that occur when the body overreacts to typically harmless substances known as allergens. Upon initial exposure, the immune system sensitizes to the allergen, producing specific antibodies, particularly immunoglobulin E (IgE). Upon subsequent exposure, the allergen binds to IgE on the surface of mast cells and basophils, triggering the release of inflammatory mediators like histamine. Histamine and other chemicals cause the classic symptoms of allergic reactions, including itching, swelling, redness, and, in severe cases, difficulty breathing and anaphylaxis. Allergic reactions can manifest in various forms, affecting the skin (hives, eczema), respiratory system (rhinitis, asthma), gastrointestinal tract, or the entire body. Allergies can develop at any age, and both genetic and environmental factors influence susceptibility. Public awareness, education, and ongoing research are essential for effective prevention, diagnosis, and management of allergic reactions. The severity of allergic reactions varies, ranging from mild discomfort to life-threatening emergencies. Diagnosis involves medical history, physical examination, and sometimes allergen-specific testing. Management includes allergen avoidance, medications such as antihistamines and epinephrine for severe reactions, and immunotherapy for long-term desensitization.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India